MUVON Therapeutics hits key milestone in stress incontinence treatment
MUVON Therapeutics - 09-Jan-2025Phase 2 results drive development ahead of 2025 J.P. Morgan Healthcare Conference
Join the club for FREE to access the whole archive and other member benefits.
Phase 2 results drive development ahead of 2025 J.P. Morgan Healthcare Conference
Early clinical trials show safety and feasibility of Muvon's innovative cell-based treatment
Muvon therapeutics unveils phase I results, paving the way for innovative muscle repair
No resources found!
No blog posts found!